PerCP anti-mouse CD45 Antibody

Product Details

Verified Reactivity

Mouse

Antibody Type

Monoclonal

Host Species

Rat

Immunogen

Mouse thymus or spleen

Formulation

Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.

Preparation

The antibody was purified by affinity chromatography, and conjugated with PerCP under optimal conditions.

Concentration

0.2 mg/ml

Storage & Handling

The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.

Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 10⁶ cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP has a maximum absorption of 482 nm and a maximum emission of 675 nm.

Excitation Laser

Blue Laser (488 nm)

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation³, complement-dependent cytotoxicity^1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)^4,6, Western blotting⁷, and spatial biology (IBEX)^10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)

1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
8. Liu F, et al. 2012. Blood. 119:3295. PubMed
9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed

Product Citations

1. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
2. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
3. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
4. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
5. Filipello F et al. 2018. Immunity. 48(5):979-991 . PubMed
6. Haratani K, et al. 2019. J Clin Invest. 130:374. PubMed
7. Keeter WC, et al. 2022. Eur Heart J Open. 2:oeac028. PubMed
8. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
9. Zhou J, et al. 2021. Int J Med Sci. 18:3516. PubMed
10. Sun J, et al. 2020. Acta Biomater. 289:106. PubMed
11. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
12. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
13. Kawashima N, et al. 2022. Nat Commun. 13:1624. PubMed
14. Lopez-Guadamillas E, et al. 2016. Sci Rep. 6:34542. PubMed
15. Stolp B, et al. 2022. Cell Rep. 38:110387. PubMed
16. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
17. Lin H, et al. 2020. Front Microbiol. 1.330555556. PubMed
18. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
19. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
20. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
21. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
22. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
23. Tajfirouz D, et al. 2017. Virology. 10.1016/j.virol.2017.02.022. PubMed
24. Zhang C, et al. 2021. Clin Transl Immunology. 10:e1310. PubMed
25. She L, et al. 2021. JCI Insight. 6:e143509. PubMed
26. Ayasoufi K, et al. 2020. Brain. 3629:143. PubMed
27. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
28. Liu YJ, et al. 2020. Theranostics. 10:5225. PubMed
29. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
30. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
31. Law HL, et al. 2020. Front Pharmacol. 11:274. PubMed
32. Sears SM, et al. 2020. Am J Physiol Renal Physiol. 319:F674. PubMed
33. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
34. Gabbita S, et al. 2015. PLoS One. 10: e0137305. PubMed
35. Ngamsri KC, et al. 2021. Int J Mol Sci. 22:. PubMed
36. Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
37. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
38. Taube C, et al. 2011. PLoS One. 6:e21799. PubMed
39. Yang S, et al. 2019. Nat Commun. 10:2782. PubMed
40. Fatkhullina AR et al. 2018. Immunity. 49(5):943-957 . PubMed
41. Zou J, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:983. PubMed
42. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
43. Everard A, et al. 2014. Nat Commun. 5:5648. PubMed
44. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
45. Demandt JAF, et al. 2021. Frontiers in Cell and Developmental Biology. 9:664258. PubMed
46. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
47. Kumaran Satyanarayanan S, et al. 2019. Nat Commun. 10:3471. PubMed
48. Arcangeli S, et al. 2022. J Clin Invest. 132: . PubMed
49. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
50. Mulder K, et al. 2021. Immunity. 54(8):1883-1900.e5. PubMed
51. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
52. Davis M, et al. 2015. J Immunol. 194:2219. PubMed
53. West D, et al. 2014. J Immunol. 192:1762. PubMed
54. Wang F, et al. 2019. Cell Death Dis. 1.036111111. PubMed
55. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
56. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
57. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
58. Wells KL, et al. 2020. Elife. 9:. PubMed
59. Wang X, et al. 2018. Cell Death Dis. 9:578. PubMed
60. Oldrini B, et al. 2018. Nat Commun. 9:1466. PubMed
61. Xiong X et al. 2019. Mol Cell. 75(3):644-660 . PubMed
62. She L, et al. 2019. J Immunol. 203:2520. PubMed
63. Bogie JFJ, et al. 2021. J Autoimmun. 124:102723. PubMed
64. Kovacs M, et al. 2021. Acta Neuropathol Commun. 9:136. PubMed
65. Lü X, et al. 2021. Exp Ther Med. 22:1005. PubMed
66. Voss M, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L188 - L195. PubMed
67. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
68. Rangaraju S, et al. 2018. Mol Neurodegener. 13:24. PubMed
69. Chulpanova DS, et al. 2021. Biology (Basel). 10:. PubMed
70. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
71. Blanchard L, et al. 2022. STAR Protoc. 3:101444. PubMed
72. Wang X, et al. 2020. Nat Commun. 4.505555556. PubMed
73. Peñaloza HF, et al. 2018. Biochem Biophys Rep. 13:12. PubMed
74. Zhang S, et al. 2022. Nat Commun. 13:4744. PubMed
75. Li X, et al. 2021. Cell Death Dis. 12:314. PubMed
76. Woods S, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 308:912. PubMed
77. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
78. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
79. Cartwright ANR, et al. 2021. Cancer Immunol Res. 9:470. PubMed
80. Gorina R, et al. 2014. J Immunol. 192:324. PubMed
81. Kerkhofs D, et al. 2020. Theranostics. 7.022222222. PubMed
82. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
83. Gomzikova MO, et al. 2020. Pharmaceutics. 12:00. PubMed
84. Enam S, et al. 2017. Biomaterials. 10.1016/j.biomaterials.2017.07.013. PubMed
85. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
86. Yamasaki R, et al. 2014. J Exp Med. 211:1533. PubMed
87. Liu Q, et al. 2021. Adv Mater. 33:e2102852. PubMed
88. Sears SM, et al. 2022. Kidney360. 3:818. PubMed
89. Wong L, et al. 2013. J Biol Chem. 288:35170. PubMed
90. Yin X, et al. 2015. J Immunol. 194:4029. PubMed
91. SL C, et al. 2016. JCI Insight. 1: 83116. PubMed
92. Cao Z, et al. 2021. Molecular Cell. 81(17):3604-3622.e10. PubMed
93. Westrich JA, et al. 2019. Oncogene. 38:7166. PubMed
94. Bai C, et al. 2022. Exp Ther Med. 24:673. PubMed
95. Zukauskas A, et al. 2018. mSphere. 3:e00303. PubMed
96. Wang X, et al. 2021. Sci Transl Med. 13:. PubMed
97. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
98. Jaeger N, et al. 2020. Cell Rep. 33:108331. PubMed
99. Chen R, et al. 2019. Mol Med Rep. 1.172916667. PubMed
100. Chuang LT, et al. 2021. Molecules. 26:. PubMed
101. Buschor S, et al. 2017. PLoS Pathogens. 13(6):e1006476. PubMed

RRID

AB_893343 (BioLegend Cat. No. 103129)
AB_893339 (BioLegend Cat. No. 103130)

Antigen Details

Structure

Protein tyrosine phosphatase (PTP) family, 180-240 kD

Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function

Phosphatase, T and B cell activation

Ligand/Receptor

Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1

Cell Type

B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs

Biology Area

Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells

Molecular Family

CD Molecules

Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID

19264 View all products for this Gene ID

UniProt

View information about CD45 on UniProt.org

Documentation

• Technical data sheet
• Certificate of Analysis
• Safety Data Sheet

Reviews

Related Protocols

• Cell Surface Flow Cytometry Staining Protocol

Related Pages & Pathways

Related FAQs

How stable is PerCP/Cy5.5 tandem as compared to PerCP alone?

PerCP/Cy5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

Certificate of Analysis